Compra online de Lucius Revumenib

Compra online de Lucius Revumenib

Price range: EUR 242.67 through EUR 1,282.67

3,000+ vendidos
Preco promocional

Farmacia fisica em Hong Kong, 100% de autenticidade garantida

Destaques do produto

FDA Revuforj / REVUMENIB Syndax Pharmaceuticals, Inc. ORAL 1 INDICATIONS AND USAGE REVUFORJ is a menin inhibitor indicated for: the treatment of relapsed or refractory acute leukemia with a lysine methyltransferase 2A gene ( KMT2A ) translocation as determined by an FDA-authorized test in adult and pediatric patients 1 year and older. ( 1 ) the t

Garantias de servico

Envio direto internacionalFarmacia autorizadaRevisado por farmaceuticoGarantia de autenticidade

Especificacoes

Especificacao
25mg*30 110mg*30 160mg*30
Fabricante
Lucius Pharmaceuticals
Envio
Hong Kong
SKU: n.d. Categoria: Etiqueta: Marca:

Informacoes do produto

Nome japones
Revumenib
Nome em ingles
Revumenib
Nome chines
Revumenib
Nome generico
Revumenib

Especificacoes

Especificacao
25mg*30 110mg*30 160mg*30
Fabricante
Lucius Pharmaceuticals
Envio
Hong Kong

Detalhes completos

Indicacoes

Revumenib ，

Mecanismo de acao

Revumenib Como funciona Como funciona ，

Dosagem

2 KMT2A NPM1 REVUFORJ (2.1) REVUFORJ ， ， (2.2) REVUFORJ ， (2.2, 2.3) 2.1 KMT2A KMT2A REVUFORJ [ (14.1)] FDA KMT2A ， [ ] NPM1 NPM1 REVUFORJ

Precaucoes

5 Precaucoes - ， ， (5.3, 8.1, 8.3) 5.1 REVUFORJ (DS) ， REVUFORJ ， / ，241 REVUFORJ ， 60 (25%) DS [ (6.1)] KMT2A ，DS 33% AML ，33% MPAL 9% ALL

Package Insert

Ingredients

11 REVUFORJ revumenib ， menin ， ，N- -2-[[4-[7-[[ -4-[( ) ] ] ]-2,7- [3.5] -2- ]-5- ] ]-5- -N-[1- ]-，2- -1,2,3- (1:1:1) C32H47FN6O4S●C6H8O7●H2O， 840.96 g/mol pH 1.2 6.8 ， pH 4.5

Indications

Revumenib ，

Dosagem

2 KMT2A NPM1 REVUFORJ (2.1) REVUFORJ ， ， (2.2) REVUFORJ ， (2.2, 2.3) 2.1 KMT2A KMT2A REVUFORJ [ (14.1)] FDA KMT2A ， [ ] NPM1 NPM1 REVUFORJ

Precautions

5 Precaucoes - ， ， (5.3, 8.1, 8.3) 5.1 REVUFORJ (DS) ， REVUFORJ ， / ，241 REVUFORJ ， 60 (25%) DS [ (6.1)] KMT2A ，DS 33% AML ，33% MPAL 9% ALL

Use in Pregnancy and Lactation

8.1 Como funciona[ (12.1)]，REVUFORJ REVUFORJ ， ， revumenib， ， - ， AUC 0.5 ，

Clinical Pharmacology

12 12.1 Como funciona menin ， 2A (KMT2A) KMT2A menin KMT2A KMT2A menin ， NPM1 KMT2A NPM1 ， NPM1 (AML) ， NPM1 A B D KMT2A ， revumenib menin-KMT2A t

Clinical Studies

14 14.1 KMT2A SNDX-5613-0700 REVUFORJ SNDX-5613-0700，NCT04065399 AUGMENT-101 30 ， KMT2A (R/R) 11q23 QTcF < 450 ， ≥ 60 mL/min/1.73 m²， < (ULN) 1.5 ， < ULN 3 ， > 50% ≥ 18 ， (ECOG) 0-2 16 < 18 ， (Karnofsky Performance Scale) ≥ 50 (Lansk )

Avaliacoes do produto (16)

Filtro: Todas as avaliacoes
4.8★★★★★
16 avaliacoes de clientes13 compras verificadas
+o***e· ha 3 semanas
★★★★
+t***3· ha 1 meses
Compra verificada
★★★★★

Descricao

Indicacoes

Revumenib ，

Mecanismo de acao

Revumenib Como funciona Como funciona ，

Dosagem

2 KMT2A NPM1 REVUFORJ (2.1) REVUFORJ ， ， (2.2) REVUFORJ ， (2.2, 2.3) 2.1 KMT2A KMT2A REVUFORJ [ (14.1)] FDA KMT2A ， [ ] NPM1 NPM1 REVUFORJ

Precaucoes

5 Precaucoes - ， ， (5.3, 8.1, 8.3) 5.1 REVUFORJ (DS) ， REVUFORJ ， / ，241 REVUFORJ ， 60 (25%) DS [ (6.1)] KMT2A ，DS 33% AML ，33% MPAL 9% ALL

Informacoes adicionais

Especificacao

25mg*30片, 110mg*30片, 160mg*30片